Background: Abdominal Compartment Syndrome (ACS) in severely injured patients is
Introduction
Abdominal compartment syndrome (ACS) is a well described, serious complication in severely injured patients. It is a syndrome of pathologically increased intra-abdominal pressure (IAP), normally as a result of intra-abdominal hemorrhage, use of large volumes of resuscitation fluid, or abdominal surgery. The diagnosis of ACS is confirmed if IAP exceeds 20 mmHg (i.e., high grade intra-abdominal hypertension; IAH) in combination with splanchnic hypoperfusion and subsequent organ dysfunction.
ACS was initially recognized as a typical complication among trauma populations, although it is also described in many other critically ill patient groups. Even though this complication is relatively infrequently seen, it should not be missed because of the presumed high risk of associated morbidity and mortality [1] [2] [3] [4] .
Many efforts have been made in to improve the outcome of severely injured patients over passed decades. Several developments in trauma care may have improved the outcome of ACS patients directly or indirectly. For example, the introduction of damage control resuscitation has decreased the need for large fluid resuscitation volumes [5] . The shift from crystalloids to the more liberal use of plasma and colloid or hyperosmolar solutions might have theoretically decreased the risk of extravasation of administered fluids [6] . More deliberated use of damage control surgery may have decreased the risk of iatrogenic injury or additional and unnecessary inflammatory responses [7] . Lastly, vacuum assisted temporary abdominal closure devices (TAC) have made open abdomen treatment easier and decreased the risk for secondary intra-abdominal fluid collection, edema formation, and closure problems [8] .
The World Society of the Abdominal Compartment Syndrome (WSACS) critically reviewed literature regarding these developments and subsequently introduced the Consensus Statements and Recommendations using the GRADE methodology. These statements serve as guidelines for the treatment of patients at risk for IAH/ACS and were first implemented on January 1, 2005 (but published in 2006) [9] . An updated version of these guidelines provide physicians with easy-to-use treatment algorithms [10] . The application of these algorithms have resulted in a decrease of ACS mortality in a mixed population of trauma and non-trauma patients [11] .
It is however unclear to what extent these developments have affected the ACS prevalence and ACS mortality among severely injured patients. The primary aim of this study was to determine the prevalence and mortality rate of ACS among severely injured patients, as well as in three subgroups of 1) severely injured patients admitted to the Intensive Care Unit (ICU), 2) patients who have sustained visceral injury, and 3) patients who have undergone trauma laparotomy, based upon available literature. The secondary aim was to compare prevalence and mortality rates of studies performed before January 1, 2005 with those performed after that date.
Methods
This systematic literature review was conducted and reported according to the standards set out in Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) [12] 
Ethics statement
The current study used secondary data, extracted from readily available literature; therefore, obtaining research ethics approval was not necessary. 
Search Strategy

Databases of Embase
Manuscript Selection
Titles and abstracts were screened independently by two reviewers (SGS and RAV) for presence of trauma populations. Inconsistencies were resolved by discussion and consensus.
Studies were included if they met the following inclusion criteria: 1) design: original reports with primary data; 2) population: presence of injured patients, and 3) outcome: description of ACS prevalence or ACS mortality numbers or data from which prevalence or mortality rates among injured patients could be calculated. No language criterion was used. Studies were excluded if no full text version was available after contacting corresponding authors. Also, studies restricted to thermally injured patients were excluded, as a systematic review on prevalence and outcome of IAH and ACS among severely burned patients is already available [13] . No specific definitions for injured patients or ACS were used as eligibility criterion.
Scientific Level of Evidence
Study classification according to Mahid et al. and the prospective-and retrospective nature of the studies were collected in order to assess the type and level of evidence of publications; randomized controlled trials (RCTs), cohort studies, and case series were found to be eligible [14] . The patient groups of RCTs were taken together, the pooled study population was considered one cohort over which prevalence or mortality rate was calculated.
Data Extraction
Data extraction was done independently in duplicate by three reviewers (SGS, OJFVW and AVVB) using a standardized data sheet. Discordance was resolved by the reviewers rechecking their extracted data until data sheets corresponded. The following data were extracted for each publication: name of first author, publication year, years the inclusion period started and ended, population size (N), type of population, age of population, mean or median injury severity score (ISS), definition used for ACS, number of ACS patients (or ACS rate), and mortality rate of ACS patients. Publications using the same patient database in overlapping periods were identified. Only data from 1) the largest or 2) most recent cohorts were used.
Data synthesis and statistical analysis
ACS prevalence and mortality rates were computed for each study; they were transformed using a double arcsine transformation in order to ensure normal distribution [15] . Next, the transformed rates and 95% confidence intervals were transformed back to prevalence and mortality rate estimates. Forest plots were constructed with 95% confidence interval for all studies to show the variation in ACS prevalence and mortality in severely injured patients across the included studies.
The Cochrane Chi-squared (χ 2 ) Q-test was applied in order to test for heterogeneity (significance set at p < 0.10), and the I 2 statistic was calculated in order to quantify the degree of between-study heterogeneity. This defines the variability percentage in effect estimates that is due to heterogeneity rather than to chance [16, 17] . An I 2 statistic greater than 40% was considered to represent significant heterogeneity.
Data were pooled using a random-effects model for binomial data (DerSimonianLaird) [18] . A random-effects model was planned a priori, due to the degree of anticipated heterogeneity among the eligible studies. If significant heterogeneity was present, subgroup analyses were planned for 'severely injured patients admitted on the ICU', 'patients with visceral injuries' and 'patients who had undergone emergent trauma laparotomy'.
For the secondary analysis the populations were divided into comparable groups with a median inclusion year before and after January 1, 2005. This date was used as cutoff, since the WSACS guideline was first implemented on that date [11] . If the inclusion period was not specified, the year of publication was used as cutoff date. Differences in ACS prevalence and mortality rates between the two time periods were tested using a unpaired Student's t test. A p-value below 0.05 was considered statistically significant.
Analyses was performed using MetaXL software (Version 2.2; Epigear International Pty Ltd, Australia; 2011-2015). Student's t test was calculated using the GraphPad QuickCalcs web site (http://graphpad.com/quickcalcs/ttest1/?Format=SEM).
Results
Trial identification
The search yielded 5,899 publications. After eliminating duplicates, 3,755 publications remained. These were reviewed for inclusion and exclusion criteria, and reference lists of reviews and eligible studies were examined for additional publications. A total of 81 publications was included in this analysis, including three randomized controlled trials, 13
prospective cohort studies, 40 retrospective cohort studies, and 25 case series ( Figure 1 ).
Extracted data of included publications are listed in SDC 2. The search identified no systematic reviews or meta-analysis regarding prevalence and mortality rate of ACS among injured patients. Only one previously published literature review listed prevalence and outcome of ACS among trauma patients in 2009. This study, however, did not describe a systematic search method [19] . One publication reported sufficient data to calculate annual prevalence between 2002 and 2007. The annual prevalences of this publication were pooled in a group before January 1, 2005 and a group after that date. These sub-groups were separately included to the different pooled populations [11] .
Prevalence of ACS in severely injured patients
The pooled prevalence of ACS for 33,455 severely injured patients in 61 publications was 4.5% (95% Confidence Interval, CI: 3.5-5.7%) with large heterogeneity (I 2 = 94.5%, 95% CI 93.6-95.4%) ( Figure 2 Figure 3C ) among severely injured patients who underwent trauma laparotomy. The pooled prevalence of these subgroups before January 1, 2005 seemed not statistically significantly different from that conducted after that date, since 95% CI's overlapped considerably. Pvalues were not calculated since 95% CI's were too skewed.
Mortality of severely injured patients with ACS
The pooled mortality for 967 severely injured patients with ACS in 42 publications was Table 2 ).
Discussion
Even though many efforts have been made the last decade to improve the outcome of ACS among severely injured patients, no significant effect on prevalence and mortality could be identified. This was unexpected, especially since the contribution of improved modern trauma care and the introduction of the Consensus Statements and Recommendations by the WSACS seem obvious steps forward in trauma care as a whole and in evidence-based treatment of ACS patients.
An obvious explanation for not finding lower prevalence and mortality rates since 2005 is the lack of adequate data. On the other hand, if prevalence and mortality rates indeed remained stable over time, our findings might indicate that modern trauma resuscitation or the WSACS guidelines are not widely known or applied in published studies. Assuming that the evidencebased treatment algorithm is effective, it is notable that its use is not frequently described in included publications. Even definitions of ACS are still not uniformly applied in modern literature [20] . A large prospective multicenter cohort study would give more clarity on the subject. Especially the use of specific and relevant inclusion criteria and uniform definitions would improve the quality of estimated prevalence and mortality of ACS among severely injured patients.
The current systematic review and meta-analysis has certain limitations due to the inherent biases of the included studies. The findings should thus be interpreted with caution. The studies had different study designs (i.e., RCT, longitudinal cohort study, or case series), diverse populations, and used different definitions of ACS. This partly explains the large between-study heterogeneity, and again outlines the need for more rigorous and uniform definitions in future studies. Despite these limitation, the strength of the current study is its robust methodology. It pooled data from 81 studies with a large overall sample size. In an attempt to minimize bias, multiple authors independently applied the eligibility criteria to the titles, abstracts, and the full-text of the articles, and subsequently collected data.
In conclusion, the pooled prevalence of ACS among severely injured patients is 4.5%. The pooled mortality of these patients is 48.3%. Even though many efforts have been made in the last decade to improve the outcome of ACS among severely injured patients, it has not yet resulted in a decrease of reported prevalence and mortality rate among these patients. Legend - Figure 4 I2, I 2 -statistic for study heterogeneity; Prev, Prevalence of mortality; Q, Cochrans Q-statistic for study heterogeneity, 95% CI, 95% Confidence Interval Studies are listen based upon publication year on the y-axis at the left hand side. Mortality rate is shown at the x-axis as fraction. The individual study mortality and corresponding 95%
Confidence Intervals and study weight as used in the pooled analysis are listen on the y-axis at the right hand side. 
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